Month: March 2023

CVB Financial Corp. Announces 134th Consecutive Cash Dividend

Written by Customer Service on March 22, 2023. Posted in Dividend Reports And Estimates.

ONTARIO, Calif., March 22, 2023 (GLOBE NEWSWIRE) — CVB Financial Corp. (NASDAQ: CVBF) (the “Company”) announced a twenty cent ($0.20) per share cash dividend with respect to the first quarter of 2023. This dividend was approved at the Company’s regularly scheduled Board of Directors meeting held on March 22, 2023. The quarterly dividend will be payable on or about April 19, 2023 to shareholders of record as of April 5, 2023. “We are pleased to announce our 134th consecutive cash dividend paid to our shareholders. This speaks to the continuing stability of Citizens Business Bank’s customer focused business model during uncertain times,” said David A. Brager, President and Chief Executive Officer. Corporate Overview CVB Financial Corp. (“CVBF”) is the holding company for Citizens Business Bank. CVBF is one of the 10 largest bank...

Wilhelmina International, Inc. Announces Fourth Quarter and Full Year 2022 Results

Written by Customer Service on March 22, 2023. Posted in Earnings Releases And Operating Results.

Annual Financial HighlightsAnnual revenues of $17.8 million for 2022 improved by 10.4% from the prior year. Annual operating income of $2.4 million for 2022 was the highest since 2014. Annual net cash flows provided by operating activities were $2.5 million in 2022. Annual pre-tax income of $2.6 million, net income of $3.5 million and Pre-Corporate EBITDA of $3.9 million for 2022. $12.0 million cash and cash equivalents at December 31, 2022 was the highest balance at the end of any quarterly or annual period in Company history Annual gross billings of $70.0 million for 2022 improved 17.9% from the prior year. (in thousands) Q4 22 Q4 21 YOYChange Year Ended 2022 Year Ended 2021 YOYChangeTotal Revenues $ 4,091 $ 4,294 (4.7%) $ 17,780 $ 16,102 10.4%Operating (Loss) Income (166 ) 149 (211.4%) 2,419 2,158 12.1%(Loss)...

Cyclerion Reports Corporate Update and Full Year 2022 Financial Results

Written by Customer Service on March 22, 2023. Posted in Earnings Releases And Operating Results.

CAMBRIDGE, Mass., March 22, 2023 (GLOBE NEWSWIRE) — Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) today announced corporate updates including advances in its zagociguat (formerly CY6463) mitochondrial disease program. The Company previously reported clinical data in adult patients with MELAS* that indicate that zagociguat may have potential as a first-ever therapy for patients with this rare, genetic mitochondrial disease. In Q4 2022, Cyclerion met with the United States Food and Drug Administration (FDA) and incorporated feedback from regulatory and mitochondrial disease clinical experts to refine the design of a Phase 2b study to evaluate zagociguat in patients with MELAS. More recently, Cyclerion filed a request with the FDA for Orphan Drug Designation and manufactured drug product to support the Phase 2b study. Given the significant...

Supply & Demand Chain Executive Recognizes Wabash’s Richard Mansilla with 2023 Pros to Know Award

Written by Customer Service on March 22, 2023. Posted in Public Companies.

LAFAYETTE, Ind., March 22, 2023 (GLOBE NEWSWIRE) — Wabash (NYSE: WNC), the visionary leader of connected solutions for the transportation, logistics and distribution industries, congratulates Vice President, Global Procurement Richard Mansilla who is recognized by Supply & Demand Chain Executive as one of the winners of the 2023 Pros to Know award. Supply & Demand Chain Executive is the only publication covering the entire global supply chain. The annual Pros to Know award recognizes outstanding executives whose accomplishments offer a roadmap for other leaders looking to leverage supply chain for competitive advantage. Winners are selected based on their professional achievements, innovations and solutions. “This year’s list is filled with supply chain professionals whose achievements and success stories have helped...

89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Written by Customer Service on March 22, 2023. Posted in Public Companies.

SAN FRANCISCO, March 22, 2023 (GLOBE NEWSWIRE) — 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced that it has commenced an underwritten public offering of $200 million of shares of its common stock or, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock. In addition, 89bio is expected to grant the underwriters of the offering an option for a period of 30 days to purchase up to an additional $30 million of shares of its common stock at the public offering price, less the underwriting discounts and commissions. The proposed public offering is subject to market and other conditions, and there...

Worthington Reports Third Quarter Fiscal 2023 Results

Written by Customer Service on March 22, 2023. Posted in Earnings Releases And Operating Results.

COLUMBUS, Ohio, March 22, 2023 (GLOBE NEWSWIRE) — Worthington Industries, Inc. (NYSE: WOR) today reported net sales of $1.1 billion and net earnings of $46.3 million, or $0.94 per diluted share, for its fiscal 2023 third quarter ended February 28, 2023. In the third quarter of fiscal 2022, the Company reported net sales of $1.4 billion and net earnings of $56.3 million, or $1.11 per diluted share. Results in both the current and prior year quarter were impacted by certain unique items, as summarized in the table below. (U.S. dollars in millions, except per share amounts) 3Q 2023 3Q 2022 After-Tax Per Share After-Tax Per Share Net earnings $ 46.3 $ 0.94 $ 56.3 $ 1.11 True-up of Level5 earnout accrual (0.8 ) (0.02 ) – – Impairment and restructuring...

Carriage Services Announces the Acquisition of Greenlawn Funeral Homes, Cemeteries and Cremations and Wood Family Funeral Service

Written by Customer Service on March 22, 2023. Posted in Mergers And Acquisitions.

HOUSTON, March 22, 2023 (GLOBE NEWSWIRE) — Carriage Services, Inc. (NYSE: CSV) Carriage Services, Inc. (“Carriage” or “Carriage Services”) is pleased to announce that it has acquired substantially all the assets of Greenlawn Funeral Homes, Cemeteries and Cremations and Wood Family Funeral Service (collectively “Greenlawn”), consisting of three funeral homes, two cemeteries, and a cremation focused business, located in the Bakersfield, California market. Jim La Mar, President and Chief Executive Officer for Greenlawn stated, “Having worked for Greenlawn since 1990, it is truly more than a business, it is my identity. As the face of our company, I could never envision placing Greenlawn’s future and wellbeing in anyone’s hands other than my own. Knowing we needed to create a succession plan so that...

Steelcase Reports Fourth Quarter and Fiscal 2023 Results

Written by Customer Service on March 22, 2023. Posted in Earnings Releases And Operating Results.

Fourth quarter results:Revenue and earnings growth driven by year-over-year pricing benefits Operating margin improved 330 basis points compared to prior year driven by gross margin improvement Year-over-year order declines moderated to 8% in fourth quarter compared to 17% in third quarterFiscal 2023 results:Company delivered 17% revenue growth and significant earnings improvement despite challenging environmentOutlook:First quarter guidance reflects continued year-over-year earnings improvement Company targets fiscal 2024 earnings growth driven largely by pricing benefitsGRAND RAPIDS, Mich., March 22, 2023 (GLOBE NEWSWIRE) — Steelcase Inc. (NYSE: SCS) today reported fourth quarter revenue of $801.7 million, net income of $15.7 million, or $0.13 per share, and adjusted earnings per share of $0.19. ...

Agile Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Corporate Update

Written by Customer Service on March 22, 2023. Posted in Earnings Releases And Operating Results.

Fourth Quarter 2022 Net Revenue Increased 33% from Third Quarter 2022 While GAAP Quarter-Over-Quarter OPEX Decreased 55% and Non-GAAP OPEX Remained Unchanged Twirla Demand and Factory Sales Up 25% and 30% Respectively in Fourth Quarter 2022 vs Third Quarter 2022 Company Reaffirms Expected Full Year 2023 Net Revenue in Range of $25-$30 Million Management to Host Conference Call Today, Wednesday, March 22, 2023 at 4:30 p.m. ET PRINCETON, N.J., March 22, 2023 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today reported financial results for the three and twelve months ended December 31, 2022 and provided a corporate update. “2022 was a turning point for Agile as we continued to advance revenue growth for Twirla and transformed and streamlined our operating model to reduce expenses,...

Atossa Therapeutics Announces Year-End 2022 Financial Results and Provides Corporate Update

Written by Customer Service on March 22, 2023. Posted in Earnings Releases And Operating Results.

SEATTLE, March 22, 2023 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant unmet needs in cancer, today announced financial results for the fiscal quarter and fiscal year ended December 31, 2022 and provided an update on recent company developments. Key developments from Q4 2022 and year to date include: Initiation and First Patient Dosed in Phase 2 EVANGELINE Study – EVANGELINE (Endoxifen Versus exemestANe GosEreLIn), is our Phase 2 randomized non-inferiority study of (Z)-endoxifen compared to exemestane plus goserelin as a neoadjuvant treatment for premenopausal women with Grade 1 or 2 ER+ / HER2- breast cancer. Participants receive neoadjuvant treatment for up to six months, followed by surgery. Several FDA-approved...

Month: March 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals